![]() |
Lung Cancer |
Free Subscription
1 Ann Surg Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
ASO Visual Abstract: Thoracic Adipose Volume is Associated with Occult Nodal
Disease- and Disease-Free Survival in Females with Clinically Node Negative
Non-Small Cell Lung Cancer.
Ann Surg Oncol. 2025 Jun 14. doi: 10.1245/s10434-025-17634.
PubMed
Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically
Resected Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00526.
PubMed
Abstract available
Globally Recognised Difficulties in Lung Cancer Care Management That May Lead to
Poor Outcomes.
Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00527.
PubMed
From Broadening to Optimizing: Refining Approach to Lung Cancer Screening
Criteria.
Ann Thorac Surg. 2025 Jun 13:S0003-4975(25)00518.
PubMed
Correction: Impact of metabolic and nutritional disorders on the synergy between
radiotherapy and immunotherapy in non-small-cell lung cancer.
BMC Cancer. 2025;25:1019.
PubMed
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE)
alone or in combination with nivolumab as frontline therapy for extensive-stage
small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.
Cancer. 2025;131:e35938.
PubMed
Abstract available
Effect of Metformin on vascular endothelial injury in patients with non-small
cell lung cancer treated with chemotherapy combined with bevacizumab.
Cancer Chemother Pharmacol. 2025;95:59.
PubMed
Abstract available
Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates
chemosensitivity in lung cancer cells.
Cancer Lett. 2025 Jun 13:217877. doi: 10.1016/j.canlet.2025.217877.
PubMed
Abstract available
AI-based radiomic features predict outcomes and the added benefit of
chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A
multi-institutional study.
Cancer Lett. 2025;628:217872.
PubMed
Abstract available
Age-Associated Modulation of TREM1/2-Expressing Macrophages Promotes Melanoma
Progression and Metastasis.
Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-4317.
PubMed
Abstract available
Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and
Responses to Targeted Therapies.
Clin Lung Cancer. 2025;26:354-363.
PubMed
Abstract available
Correlation of PET-CT, Endobronchial Ultrasound Cytology and Surgical Biopsy in
Patients with Non-Small Cell Lung Cancer Undergoing Curative Surgery.
Clin Lung Cancer. 2025 May 18:S1525-7304(25)00103.
PubMed
Abstract available
Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients
With EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Case series.
Clin Lung Cancer. 2025 May 29:S1525-7304(25)00125.
PubMed
Prevalence and characteristics of lung cancer in families harboring Pathogenic
Germline Variants in cancer predisposing genes: A 20-year retrospective analysis.
Eur J Cancer. 2025;225:115571.
PubMed
Abstract available
Lung cancer screening in Europe: a golden opportunity to address tobacco use
through scalable, WHO-guided cessation interventions.
Eur Respir J. 2025;65:2500124.
PubMed
Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia:
An expert opinion.
Int J Cancer. 2025 Jun 14. doi: 10.1002/ijc.35512.
PubMed
Abstract available
Development and interpretation of machine learning-based prognostic models for
predicting high-risk prognostic pathological components in pulmonary nodules:
integrating clinical features, serum tumor marker and imaging features.
J Cancer Res Clin Oncol. 2025;151:190.
PubMed
Abstract available
Targeting WEE1 to overcome ARID1A mutation-driven osimertinib resistance in
EGFR-mutant lung cancer.
J Thorac Oncol. 2025 Jun 13:S1556-0864(25)00766.
PubMed
Abstract available
Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell
lung cancer.
Lancet. 2025;405:2104-2106.
PubMed
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as
first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302):
4-year outcomes from a double-blind, randomised, phase 3 trial.
Lancet Oncol. 2025 Jun 13:S1470-2045(25)00198.
PubMed
Abstract available
Prevalence and prognostic significance of interstitial lung abnormalities in lung
cancer: A meta-analysis.
Lung Cancer. 2025;205:108458.
PubMed
Abstract available
Efficacy of immune checkpoint inhibitors (ICIs) in PD-L1 negative Non-Small Cell
Lung Cancer (NSCLC) - A meta-analysis based on reconstructed individual
participant data.
Lung Cancer. 2025;205:108621.
PubMed
Abstract available
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b
trial.
Nat Med. 2025;31:1949-1957.
PubMed
Abstract available
Dichotomous roles of ACBD3 in NSCLC growth and metastasis.
Oncogene. 2025;44:2078-2090.
PubMed
Abstract available
Cancer disrupts sex hormone-inflammation relationships: Analysis of ALI in males
from NHANES 2007-2018.
PLoS One. 2025;20:e0325796.
PubMed
Abstract available
Retraction: Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor.
PLoS One. 2025;20:e0326513.
PubMed
AKR1C2 silencing promotes ferroptosis and inhibits proliferation, migration, and
invasion in lung cancer cells.
PLoS One. 2025;20:e0325995.
PubMed
Abstract available
Latent class analysis of depression among patients with non-small cell lung
cancer after surgery: A cross-sectional study.
PLoS One. 2025;20:e0324723.
PubMed
Abstract available
Tumor-promoting UBR4 coordinates impaired mitophagy-associated senescence and
lung adenocarcinoma pathogenesis.
Proc Natl Acad Sci U S A. 2025;122:e2425015122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.